Publication:
Impact of harm reduction care in HIV clinical settings on stigma and health outcomes for people with HIV who use drugs: study protocol for a mixed-methods, multisite, observational study

dc.contributor.coauthorKay, Emma Sophia
dc.contributor.coauthorCreasy, Stephanie
dc.contributor.coauthorBatey, D. Scott
dc.contributor.coauthorCoulter, Robert
dc.contributor.coauthorEgan, James E.
dc.contributor.coauthorFisk, Stuart
dc.contributor.coauthorFriedman, Mackey Reuel
dc.contributor.coauthorKinsky, Suzanne
dc.contributor.coauthorKrier, Sarah
dc.contributor.coauthorNoble, Victor
dc.contributor.coauthorTuran, Janet M.
dc.contributor.coauthorYu, Lan
dc.contributor.coauthorHawk, Mary
dc.contributor.departmentDepartment of Psychology
dc.contributor.kuauthorTuran, Bülent
dc.contributor.schoolcollegeinstituteCollege of Social Sciences and Humanities
dc.date.accessioned2024-11-09T12:26:49Z
dc.date.issued2022
dc.description.abstractIntroduction: our previous pilot work suggests relational harm reduction strengthens relationships between people with HIV (PWH) who use drugs and their healthcare providers and improves HIV health outcomes. However, there is limited research examining ways that structural (eg, strategies like syringe service programmes) and/or relational (patient-provider relationship) harm reduction approaches in HIV clinical settings can mitigate experiences of stigma, affect patient-provider relationships and improve outcomes for PWH who use drugs. Our mixed methods, multisite, observational study aims to fill this knowledge gap and develop an intervention to operationalise harm reduction care for PWH who use drugs in HIV clinical settings. Methods and analysis: aim 1 will explore the relationship between healthcare providers' stigmatising attitudes towards working with PWH who use drugs and providers' acceptance and practice of structural and relational harm reduction through surveys (n=125) and interviews (n=20) with providers. Aim 2 will explore the interplay between patient-perceived harm reduction, intersectional stigma and clinical outcomes related to HIV, hepatitis C (if applicable) and substance use-related outcomes through surveys (n=500) and focus groups (k=6, total n=36) with PWH who use drugs. We will also psychometrically evaluate a 25-item scale we previously developed to assess relational harm reduction, the Patient: assessment of Provider Harm Reduction Scale. Aim 3: will use human-centred design approaches to develop and pretest an intervention to operationalise harm reduction care for PWH who use drugs in HIV clinical settings. Ethics and dissemination: this study was approved via expedited review by the University of Pittsburgh Institutional Review: board (STUDY21090002). Study: findings will be presented in peer-reviewed journals and public health conferences as well as shared with patient participants, community advisory boards and harm reduction organisations.
dc.description.fulltextYES
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue9
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipFunding for this study was provided by the US National Institutes of Health, National Institute on Drug Abuse (1R01DA054832--01). The funder had no role in the design of the study, data collection, data analyses, interpretation of data, or preparation of this manuscript.
dc.description.versionPublisher version
dc.description.volume12
dc.identifier.doi10.1136/bmjopen-2022-067219
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR04035
dc.identifier.issn2044-6055
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85138207610
dc.identifier.urihttps://doi.org/10.1136/bmjopen-2022-067219
dc.identifier.wos859769800018
dc.keywordsHIV and AIDS
dc.keywordsPublic health
dc.keywordsSubstance misuse
dc.language.isoeng
dc.publisherBMJ Publishing Group
dc.relation.grantnoNA
dc.relation.ispartofBMJ Open
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10917
dc.subjectMedicine, general and internal
dc.titleImpact of harm reduction care in HIV clinical settings on stigma and health outcomes for people with HIV who use drugs: study protocol for a mixed-methods, multisite, observational study
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorTuran, Bülent
local.publication.orgunit1College of Social Sciences and Humanities
local.publication.orgunit2Department of Psychology
relation.isOrgUnitOfPublicationd5fc0361-3a0a-4b96-bf2e-5cd6b2b0b08c
relation.isOrgUnitOfPublication.latestForDiscoveryd5fc0361-3a0a-4b96-bf2e-5cd6b2b0b08c
relation.isParentOrgUnitOfPublication3f7621e3-0d26-42c2-af64-58a329522794
relation.isParentOrgUnitOfPublication.latestForDiscovery3f7621e3-0d26-42c2-af64-58a329522794

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
10917.pdf
Size:
877.51 KB
Format:
Adobe Portable Document Format